<DOC>
	<DOCNO>NCT00693225</DOCNO>
	<brief_summary>The purpose study determine effect morning versus bedtime administration omeprazole/sodium bicarbonate ( Zegerid ) endoscopic heal patient moderate severe reflux esophagitis . Our hypothesis bedtime administration Zegerid would superior heal esophagitis compare morning administration prior meal .</brief_summary>
	<brief_title>Impact Timing Efficacy Zegerid 40 mg Healing Reflux Esophagitis : A Pilot Study</brief_title>
	<detailed_description>Hypothesis : The timing administration omeprazole/sodium bicarbonate ( Zegerid ) impact nocturnal esophageal acid exposure heal esophagitis . Specifically , hypothesize omeprazole/sodium bicarbonate , take bedtime , superior heal esophagitis compare omeprazole/sodium bicarbonate take morning . Specific Aim : Compare percent subject moderate/severe esophagitis achieve complete endoscopic resolution 8 week treatment ( morning vs. bedtime ) . Intervention : All subject receive one-on-one educational session describe normal physiology upper gastrointestinal tract , pathophysiology hiatal hernia reflux esophagitis , food stuff contribute reflux , prior invitation participate trial . Outpatients underwent clinically indicate esophagogastroduodenoscopy ( EGD ) advise primary health care provider open-access endoscopy unit diagnose Los Angeles grade C D erosive reflux esophagitis invite participate . Omeprazole/sodium bicarbonate powder oral suspension 40 mg supply individual packet empty small cup contain 15-30 ml ( 1-2 tablespoon ) water , one per day , 8 week . They ask stir well drink immediately refill cup water drink . Subjects assign morning dosing instruct take medication empty stomach , immediately upon rise , 20 60 minute prior chew solid . Subjects assign bedtime dose instruct keep medication bedside ; take medication stand seat upright position immediately turn light intention sleep . The subject instruct use liquid food 20 minute take study medication allocate morning dosing , next morning allocate bedtime dosing . Gelusil™ distribute use `` demand '' rescue antacid ; frequency use record plan use Gelusil™ consumption potential confounder omeprazole/sodium bicarbonate efficacy . Other antacid , include sodium bicarbonate , magnesium hydroxide , calcium carbonate , sucralfate prohibit . Subjects take non-omeprazole proton pump inhibitor ( PPIs ) and/or Histamine Receptor Antagonist ( HRAs ) advise discontinue medication participate study . No medication alter study . After 8 week , follow-up EGD perform assess mucosal integrity endoscopist blind study subject allocation .</detailed_description>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Esophagitis , Peptic</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Omeprazole , sodium bicarbonate drug combination</mesh_term>
	<criteria>1 . Subjects either moderate severe erosive esophagitis ( Los Angeles grade C D ) 2 . Subjects esophagitis despite use nonomeprazole Proton Pump Inhibitor ( PPI ) ( ) histamine receptor antagonist ( HRA ) invite participate without washout period . 3 . Subjects able return Mayo Clinic Rochester follow endoscopy 8 week start study . 4 . Female subject eligible pregnant lactate one follow criterion meet : 1 . Surgically sterile ( mean hysterectomy bilateral tubal ligation ) . 2 . At least one year postmenopausal ( menses great equal 12 month ) . 3 . Subject use highly effective method contraception , childbearing potential negative urine human chorionic gonadotropin beta subunit ( BHCG ) pregnancy test screening , prior trial drug administration . 1 . Subjects already fail omeprazole past , intolerant PPI therapy 2 . Subjects use clopidogrel ( Plavix ) 3 . Subjects one follow diagnosis : 1 . Neoplasm esophagus stomach 2 . Previous upper gastrointestinal surgery ( esophagectomy , Heller myotomy , hiatal hernial repair ) 3 . Diabetic gastroparesis 4 . Esophageal motility disorder : Achalasia scleroderma 5 . ZollingerEllison syndrome 6 . Infection human immunodeficiency virus ( HIV ) 7 . Bleeding diathesis 8 . History gastric small bowel obstruction 9 . Inability read due blindness , cognitive dysfunction , English language illiteracy 10 . Disorders predispose unreliable response Schizophrenia , Alzheimer 's disease significant memory loss 11 . Pregnant lactating female exclude PPIs think safe fetus ( Pregnancy Category C ) . 4 . Children young 18 year age exclude compliance might dictate others , parent , result would generalizable adult population . Other vulnerable population , diminish mental acuity , exclude reason . 5 . Residence outside US ( due difficulty overseas postal service ) prison .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Erosive Esophagitis</keyword>
	<keyword>Reflux Esophagitis</keyword>
	<keyword>Gastroesophageal reflux disease</keyword>
	<keyword>GERD</keyword>
	<keyword>proton pump inhibitor</keyword>
	<keyword>omeprazole/sodium bicarbonate</keyword>
</DOC>